In patients with HCC, the expression of PD-1 was increased in CD8+ T cells [10], and the high frequency of both circulating and tumor-infiltrating PD-1+ CD8+ T cells was associated with progression following curative hepatic resection in patients who were never treated via immunotherapy [11]. The gene discussed is CD8A; the disease is neoplasm.